Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up

…, H Hartmann, G Scharer… - Molecular genetics and …, 2011 - Elsevier
Antiquitin (ATQ) deficiency is the main cause of pyridoxine dependent epilepsy characterized
by early onset epileptic encephalopathy responsive to large dosages of pyridoxine. …

Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5

…, MA Swanson, T Shaikh, K Bhattacharya, GH Scharer… - Brain, 2014 - academic.oup.com
Patients with nonketotic hyperglycinemia and deficient glycine cleavage enzyme activity,
but without mutations in AMT, GLDC or GCSH, the genes encoding its constituent proteins, …

[PDF][PDF] A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases

…, D Oh, MJ Owen, G Powley, G Scharer… - The American Journal of …, 2022 - cell.com
Newborn screening (NBS) dramatically improves outcomes in severe childhood disorders
by treatment before symptom onset. In many genetic diseases, however, outcomes remain …

[HTML][HTML] An automated 13.5 hour system for scalable diagnosis and acute management guidance for genetic diseases

…, CM Kunard, DP Dimmock, LD Smith, G Scharer… - Nature …, 2022 - nature.com
While many genetic diseases have effective treatments, they frequently progress rapidly to
severe morbidity or mortality if those treatments are not implemented immediately. Since front-…

Folinic acid–responsive seizures are identical to pyridoxine‐dependent epilepsy

RC Gallagher, JLK Van Hove, G Scharer… - Annals of Neurology …, 2009 - Wiley Online Library
Objective Folinic acid–responsive seizures and pyridoxine‐dependent epilepsy are two
treatable causes of neonatal epileptic encephalopathy. The former is diagnosed by …

[PDF][PDF] An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1

HC Yu, JL Sloan, G Scharer, A Brebner… - The American Journal of …, 2013 - cell.com
Derivatives of vitamin B 12 (cobalamin) are essential cofactors for enzymes required in
intermediary metabolism. Defects in cobalamin metabolism lead to disorders characterized by …

Prediction of long‐term outcome in glycine encephalopathy: a clinical survey

…, JM Berger, U Grieben, G Scharer… - Journal of Inherited …, 2012 - Wiley Online Library
Objective Glycine encephalopathy (GE) is a rare autosomal recessive inborn error of glycine
degradation resulting in severe encephalopathy with ensuing poor outcome. Attenuated …

Genomics in clinical practice: lessons from the front lines

…, J Northup, A Roquemore-Goins, G Scharer… - Science translational …, 2013 - science.org
The price of whole-genome and -exome sequencing has fallen to the point where these
methods can be applied to clinical medicine. Here, we outline the lessons we have learned in …

[HTML][HTML] Clinical impact of copy number variation analysis using high-resolution microarray technologies: advantages, limitations and concerns

CR Coughlin, GH Scharer, TH Shaikh - Genome medicine, 2012 - Springer
Copy number variation (CNV) analysis has had a major impact on the field of medical
genetics, providing a mechanism to identify disease-causing genomic alterations in an …

Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia

MA Swanson, CR Coughlin Jr, GH Scharer… - Annals of …, 2015 - Wiley Online Library
Objective Nonketotic hyperglycinemia is a neurometabolic disorder characterized by intellectual
disability, seizures, and spasticity. Patients with attenuated nonketotic hyperglycinemia …